These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29956116)

  • 1. The Role of Religious Service Attendance, Psychosocial and Behavioral Determinants of Antiretroviral Therapy (ART) Adherence: Results from HPTN 063 Cohort Study.
    Ransome Y; Mayer KH; Tsuyuki K; Mimiaga MJ; Rodriguez-Diaz CE; Srithanaviboonchai K; Friedman RK; Limbada M; Safren SA;
    AIDS Behav; 2019 Feb; 23(2):459-474. PubMed ID: 29956116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Longitudinal Effects of Non-injection Substance Use on Sustained HIV Viral Load Undetectability Among MSM and Heterosexual Men in Brazil and Thailand: The Role of ART Adherence and Depressive Symptoms (HPTN 063).
    Tsuyuki K; Shoptaw SJ; Ransome Y; Chau G; Rodriguez-Diaz CE; Friedman RK; Srithanaviboonchai K; Li S; Mimiaga MJ; Mayer KH; Safren SA
    AIDS Behav; 2019 Mar; 23(3):649-660. PubMed ID: 30725397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.
    Jones HS; Floyd S; Stangl A; Bond V; Hoddinott G; Pliakas T; Bwalya J; Mandla N; Moore A; Donnell D; Bock P; Fidler S; Hayes R; Ayles H; Hargreaves JR;
    Trop Med Int Health; 2020 Oct; 25(10):1246-1260. PubMed ID: 32745296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia.
    Denison JA; Koole O; Tsui S; Menten J; Torpey K; van Praag E; Mukadi YD; Colebunders R; Auld AF; Agolory S; Kaplan JE; Mulenga M; Kwesigabo GP; Wabwire-Mangen F; Bangsberg DR
    AIDS; 2015 Jan; 29(3):361-71. PubMed ID: 25686684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to antiretroviral therapy (ART) during the early months of treatment in rural Zambia: influence of demographic characteristics and social surroundings of patients.
    Sasaki Y; Kakimoto K; Dube C; Sikazwe I; Moyo C; Syakantu G; Komada K; Miyano S; Ishikawa N; Kita K; Kai I
    Ann Clin Microbiol Antimicrob; 2012 Dec; 11():34. PubMed ID: 23270312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Early Antiretroviral Therapy: Results From HPTN 052, a Phase III, Multinational Randomized Trial of ART to Prevent HIV-1 Sexual Transmission in Serodiscordant Couples.
    Safren SA; Mayer KH; Ou SS; McCauley M; Grinsztejn B; Hosseinipour MC; Kumarasamy N; Gamble T; Hoffman I; Celentano D; Chen YQ; Cohen MS;
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):234-40. PubMed ID: 26009832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the impact of HIV support groups on antiretroviral therapy adherence and viral suppression in the African cohort study.
    Mbah P; Iroezindu M; Esber AL; Dear N; Reed D; Adamu Y; Tiamiyu AB; Mohammed SS; Kibuuka H; Maswai J; Owuoth J; Bahemana E; Ake JA; Polyak CS; Crowell TA;
    BMC Infect Dis; 2021 Jul; 21(1):694. PubMed ID: 34281502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examination of the Role of Religious and Psychosocial Factors in HIV Medication Adherence Rates.
    Dalmida SG; McCoy K; Koenig HG; Miller A; Holstad MM; Thomas T; Clayton-Jones D; Grant M; Fleming T; Wirani MM; Mugoya G
    J Relig Health; 2017 Dec; 56(6):2144-2161. PubMed ID: 28285439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362.
    Cohn SE; Jiang H; McCutchan JA; Koletar SL; Murphy RL; Robertson KR; de St Maurice AM; Currier JS; Williams PL
    AIDS Care; 2011 Jun; 23(6):775-85. PubMed ID: 21293986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to antiretroviral treatment and associated factors among people living with HIV and AIDS in CHITWAN, Nepal.
    Neupane S; Dhungana GP; Ghimire HC
    BMC Public Health; 2019 Jun; 19(1):720. PubMed ID: 31182074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Social and economic barriers to adherence among patients at Livingstone General Hospital in Zambia.
    Moomba K; Van Wyk B
    Afr J Prim Health Care Fam Med; 2019 Apr; 11(1):e1-e6. PubMed ID: 31038336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    Mody A; Eshun-Wilson I; Sikombe K; Schwartz SR; Beres LK; Simbeza S; Mukamba N; Somwe P; Bolton-Moore C; Padian N; Holmes CB; Sikazwe I; Geng EH
    PLoS Med; 2019 Oct; 16(10):e1002959. PubMed ID: 31661487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported antiretroviral therapy adherence and viral load in criminal justice-involved populations.
    Cunningham WE; Nance RM; Golin CE; Flynn P; Knight K; Beckwith CG; Kuo I; Spaulding A; Taxman FS; Altice F; Delaney JA; Crane HM; Springer SA
    BMC Infect Dis; 2019 Oct; 19(1):913. PubMed ID: 31664910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda.
    Haberer JE; Musinguzi N; Boum Y; Siedner MJ; Mocello AR; Hunt PW; Martin JN; Bangsberg DR
    J Acquir Immune Defic Syndr; 2015 Dec; 70(4):386-92. PubMed ID: 26110445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    Hayes R; Floyd S; Schaap A; Shanaube K; Bock P; Sabapathy K; Griffith S; Donnell D; Piwowar-Manning E; El-Sadr W; Beyers N; Ayles H; Fidler S;
    PLoS Med; 2017 May; 14(5):e1002292. PubMed ID: 28464041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    Floyd S; Shanaube K; Yang B; Schaap A; Griffith S; Phiri M; Macleod D; Sloot R; Sabapathy K; Bond V; Bock P; Ayles H; Fidler S; Hayes R;
    PLoS Med; 2020 Apr; 17(4):e1003067. PubMed ID: 32240156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Socioeconomic marginalization and plasma HIV-1 RNA nondetectability among individuals who use illicit drugs in a Canadian setting.
    Richardson LA; Kerr TH; Dobrer S; Puskas CM; Guillemi SA; Montaner JS; Wood E; Milloy MJ
    AIDS; 2015 Nov; 29(18):2487-95. PubMed ID: 26558546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. At-Risk Alcohol Use is Associated with Antiretroviral Treatment Nonadherence Among Adults Living with HIV/AIDS.
    Paolillo EW; Gongvatana A; Umlauf A; Letendre SL; Moore DJ
    Alcohol Clin Exp Res; 2017 Aug; 41(8):1518-1525. PubMed ID: 28679147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Disclosure of HIV Status and Associations with Psychological Factors, ART Non-Adherence, and Viral Load Non-Suppression Among People Living with HIV in the UK.
    Daskalopoulou M; Lampe FC; Sherr L; Phillips AN; Johnson MA; Gilson R; Perry N; Wilkins E; Lascar M; Collins S; Hart G; Speakman A; Rodger AJ;
    AIDS Behav; 2017 Jan; 21(1):184-195. PubMed ID: 27586375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Failure in HIV-Infected Children on Second-line Protease Inhibitor-Based Antiretroviral Therapy.
    Suaysod R; Ngo-Giang-Huong N; Salvadori N; Cressey TR; Kanjanavanit S; Techakunakorn P; Krikajornkitti S; Srirojana S; Laomanit L; Chalermpantmetagul S; Lallemant M; Le Cœur S; McIntosh K; Traisathit P; Jourdain G
    Clin Infect Dis; 2015 Jul; 61(1):95-101. PubMed ID: 25838288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.